SI0714910T1 - Use of a decapeptide with a benzodiazepine activity for the preparation of medicaments and dietary supplements - Google Patents

Use of a decapeptide with a benzodiazepine activity for the preparation of medicaments and dietary supplements

Info

Publication number
SI0714910T1
SI0714910T1 SI9530273T SI9530273T SI0714910T1 SI 0714910 T1 SI0714910 T1 SI 0714910T1 SI 9530273 T SI9530273 T SI 9530273T SI 9530273 T SI9530273 T SI 9530273T SI 0714910 T1 SI0714910 T1 SI 0714910T1
Authority
SI
Slovenia
Prior art keywords
decapeptide
contg
leu
medicaments
preparation
Prior art date
Application number
SI9530273T
Other languages
English (en)
Slovenian (sl)
Inventor
Laurent Miclo
Emanuel Perrin
Alain Driou
Jean-Francois Boudier
Catherine Iung
Guy Linden
Original Assignee
Ingredia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ingredia filed Critical Ingredia
Publication of SI0714910T1 publication Critical patent/SI0714910T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
SI9530273T 1994-11-30 1995-11-30 Use of a decapeptide with a benzodiazepine activity for the preparation of medicaments and dietary supplements SI0714910T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9414362A FR2727315A1 (fr) 1994-11-30 1994-11-30 Utilisation d'un decapeptide a activite de type benzodiazepine pour la preparation de medicaments et de complements alimentaires
EP95402697A EP0714910B1 (de) 1994-11-30 1995-11-30 Verwendung eines Dekapeptids mit benzodiazepinischer Wirkung zur Herstellung von Arzneimitteln und Diätzusätzen

Publications (1)

Publication Number Publication Date
SI0714910T1 true SI0714910T1 (en) 1999-10-31

Family

ID=9469315

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9530273T SI0714910T1 (en) 1994-11-30 1995-11-30 Use of a decapeptide with a benzodiazepine activity for the preparation of medicaments and dietary supplements

Country Status (10)

Country Link
US (1) US5846939A (de)
EP (1) EP0714910B1 (de)
JP (1) JP3973244B2 (de)
AT (1) ATE178615T1 (de)
DE (1) DE69508890T2 (de)
DK (1) DK0714910T3 (de)
ES (1) ES2135023T3 (de)
FR (1) FR2727315A1 (de)
GR (1) GR3030650T3 (de)
SI (1) SI0714910T1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465432B1 (en) * 2000-08-28 2002-10-15 Kraft Food Holdings, Inc. Isolated antioxidant peptides form casein and methods for preparing, isolating, and identifying antioxidant peptides
EP1275308A1 (de) * 2001-07-13 2003-01-15 The Procter & Gamble Company Lebensmittelzusammenstellung mit stresslinderenden Eigenschaften für Säugetiere
NL1032322C2 (nl) * 2006-08-15 2008-02-18 Friesland Brands Bv Slaapmelk.
FR2909879B1 (fr) * 2006-12-13 2009-03-13 Lorraine Inst Nat Polytech Utilisation d'un heptapeptide a activite anxiolytique pour la preparation de medicaments et de complements alimentaires
FR2932090B1 (fr) * 2008-06-06 2012-09-14 Lorraine Inst Nat Polytech Compositions anxiolytiques comprenant des peptides derives de la caseine alpha s1
US9532952B2 (en) 2011-01-28 2017-01-03 Physician's Seal, LLC Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients
WO2012103411A2 (en) 2011-01-28 2012-08-02 Zx Pharma, Llc Controlled-release melatonin composition and related methods
JP2019514977A (ja) 2016-05-06 2019-06-06 フィジシャンズ シール，エルエルシー バレリアン組成物及び関連方法
US10980269B2 (en) * 2016-12-12 2021-04-20 Mead Johnson Nutrition Company Protein hydrolysates and methods of making same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208240A (en) * 1991-03-12 1993-05-04 Merrell Dow Pharmaceuticals Inc. 8-substituted purines as selective adenosine receptor agents
JPH06239888A (ja) * 1993-02-18 1994-08-30 Kanebo Ltd 新規ペプチド及び鎮静剤並びに精神安定用食品

Also Published As

Publication number Publication date
DK0714910T3 (da) 1999-10-18
DE69508890D1 (de) 1999-05-12
US5846939A (en) 1998-12-08
EP0714910B1 (de) 1999-04-07
ES2135023T3 (es) 1999-10-16
DE69508890T2 (de) 1999-10-07
FR2727315A1 (fr) 1996-05-31
ATE178615T1 (de) 1999-04-15
JPH08268903A (ja) 1996-10-15
JP3973244B2 (ja) 2007-09-12
FR2727315B1 (de) 1997-02-14
EP0714910A1 (de) 1996-06-05
GR3030650T3 (en) 1999-10-29

Similar Documents

Publication Publication Date Title
CA2221455A1 (en) Pharmaceutical and/or dietetic compositions with antioxidant activity containing carnosine or derivatives and branched amino acids
EP0339656A3 (en) Lactalbumin as food supplement
CA2242114A1 (en) Nutritional supplement for the treatment and prevention of excessive intestinal permeability
CA2166003A1 (en) Method for providing nutrition to the elderly patients
CA1268123C (en) DIETARY PRODUCTS CONTAINING METHYLSULFONYLMETHANE AND THEIR USE
IL88898A0 (en) 1,2-bis(aminomethyl)-cyclo-butane-platinum complexes,their preparation and pharmaceutical compositions containing them
ES2168157T3 (es) Alimento o suplemento nutritivo, su procedimiento de preparacion y sus utilizaciones.
PT923315E (pt) Formula nutricional para pacientes com fenilcetonuria
DE69806820D1 (de) Kaloriereiche ernährungszusammensetzung
EP0189160A3 (de) Enterales Ernährungsrezept mit hohem Fettgehalt und niedrigem Kohlehydratgehalt
GR3032748T3 (en) Nutrition for persons infected with human immunodeficiency virus.
DK0626176T3 (da) Næringsmiddel til personer, som undergår stråleterapi eller kemoterapi
GR3030650T3 (en) Use of a decapeptide with a benzodiazepine activity for the preparation of medicaments and dietary supplements
ATE96327T1 (de) Nahrungsmittelzusatz.
AU8230187A (en) N,n'-bis-amino acid-l-cystine-peptide-containing amino acid preparations for oral and parenteral administration
AU7100094A (en) Rumen-bypass fatty acid salt and protein dietary supplement for ruminants
GB8821188D0 (en) Dietary supplements
HK1025562A1 (en) Solid compositions suitable for oral administration comprising l-carnitine choline tartrate
IL131956A0 (en) Solid compositions suitable for oral administration comprising non hygroscopic salts of l-carnitine and alkanoyl-l-carnitine with 2-aminoethanesulfonic acid
EP0893069A3 (de) Antioxidative Zusammensetzungen mit Süssmolkekonzentrat
Welch The effect of dietary protein concentration on zinc metabolism in ruminant Holstein calves
GAILLARD et al. The effects of marginal vitamin deficiency on mental performance
CA2034145A1 (en) Confectionery product made of protein and carbohydrate materials present in a relative weight ratio higher than 1
IT8920225A0 (it) Integratori dietetici, in particolare per condizioni di accresciuto catabolismo proteico.